Hemostasis Management

Cath Lab

Hemostasis Management

FDA Clears Cardiva Medical’s Vascade Vascular Closure System

Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Vascade Vascular Closure System (VCS). Clinical data from a prospective, multi-center, randomized 420 patient trial demons...

AccessClosure Launches MynxGrip Vascular Closure Device

February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the MynxGrip VCD offers an active, extravascular and p...

Sealing the Access Site
For decades, cath lab clinicians essentially had only one option for achieving hemostasis management following a procedure – compression. That changed in the 1990s with the introduction of vascular closure devices and hemostatic pads, which were desi...
Arteriotomy Devices Reasonable, But More Research Needed

October 6, 2010 – A new statement from the American Heart Association says arteriotomy closure devices are reasonable to use, but their benefits should be weighed against the risk of complications.

Vascular Solutions Stops Sales of R-Band Radial Hemostasis...
The U.S. District Court for the District of New Jersey approved an agreement under which Vascular Solutions Inc. will cease further manufacture, sales and...
Maquet Air-Band Radial Compression Device Receives FDA 510(...
Maquet Cardiovascular LLC has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and European CE mark approval for its new Air-Band...
Guardian II Hemostais Valve, recall
Vascular Solutions Recalls Guardian II Hemostasis Valves
The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of the Vascular Solutions Inc. Guardian II and Guardian II NC...
Terumo Files Patent Infringement Lawsuit Against Vascular...
Terumo Medical Corp. announced it filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co. Ltd. in the U.S...
Maquet Air-Band Radial Compression Device Receives FDA 510(k) Clearance, CE Mark
Maquet Cardiovascular LLC has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and European CE mark approval for
Vascade VCS Provides Temporary Hemostasis During Vascular Closure
Cardiva Medical's Vascade Vascular Closure System (VCS), an extravascular closure device, utilizes a unique delivery system based on a...
Vascular Solutions Launches R-Band Radial Hemostasis Device
Vascular Solutions is the exclusive distributor of the R-Band radial hemostasis compression device in the United States under an agreement...
AccessClosure Launches MynxGrip Vascular Closure Device
February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip...
View All »

Articles

An extracted bovine artery with an arteriotomy sealed by a MynxGrip closure dev
Bioresorbable Vascular Closure Devices Speed Ambulation
Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ambulation, reduce nursing time...
The implementation of dedicated access site surveillance and educational program
Targeted Surveillance, Training Reduces Access Site...
The implementation of dedicated access site surveillance and educational programs, in tandem with pre-existent strategies to reduce access site complications,...
TAVR, EVAR Vascular Closure Device May Eliminate Need for...
Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a...
Access site complications, hemostasis management, vascular closure
Targeted Surveillance, Training Reduces Post-PCI Access...
Percutaneous coronary interventional (PCI) procedures are performed throughout hundreds of US institutions every day. With the increasing frequency of these...

Video Center

view all Videos »

New Trends and Technology in Electrophysiology from HRS 2013
The Heart Rhythm Society (HRS) 2013 scientific sessions covered the latest research and technology...
1 week 4 days ago
The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
14 weeks 5 days ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
19 weeks 7 hours ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...